Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 USD | +10.74% |
|
+3.88% | -69.51% |
01/07 | Revance Therapeutics, Inc.(NasdaqGM:RVNC) added to Russell 3000E Index | CI |
01/07 | Revance Therapeutics, Inc.(NasdaqGM:RVNC) added to Russell Microcap Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.51% | 28Cr | |
+4.57% | 9.67TCr | |
+5.66% | 4.14TCr | |
-13.20% | 3.27TCr | |
+78.96% | 2.91TCr | |
-16.02% | 1.54TCr | |
-8.17% | 1.3TCr | |
-13.35% | 1.14TCr | |
+160.91% | 989.81Cr | |
-56.29% | 879.44Cr |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- Revance Therapeutics Forecasts Impairment Charge of Up to $100 Million Amid Restructuring, Opul Exit; Shares Fall